NanoPalm

Active

EnsaliX AI platform for designing patterned lipid nanoparticles (pLNPs) for gene and drug delivery

Riyadh, Saudi ArabiaFounded 2022

HealthTechAI & Machine Learning

Unknown

NanoPalm is a Riyadh-based deep-tech biotech company building AI-designed, chip-manufactured patterned lipid nanoparticles for in-vivo gene therapy and drug delivery, with sickle-cell disease as an early target. It began at KACST and was incubated by the NTDP/KAUST NextEra programme. It signed a joint-venture letter of intent with Rakovina Therapeutics in 2025 and was selected for Charles River's Advanced Therapy Incubator.

Founders

Ali Alhasan

Founder & CEO

Samar Al-Sudir

Co-Founder

Something here wrong?

Every figure on this page is meant to have a source behind it. If one doesn't match reality, tell us and we'll fix it.